vimarsana.com

Page 82 - குறிப்பு தொடர்பாக முன்னோக்கி பார்க்கிறது அறிக்கைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

InterPrivate Acquisition Corp Announces Stockholder Approval of Business Combination with Aeva

Share this article Share this article NEW YORK, March 11, 2021 /PRNewswire/  InterPrivate Acquisition Corp. ( InterPrivate ) (NYSE: IPV), today announced the results for the seven proposals considered and voted upon by its stockholders at its Special Meeting on March 11, 2021. InterPrivate reported that all of the proposals related to the previously announced business combination agreement between InterPrivate and Aeva Technologies, Inc. ( Aeva ) were approved by the InterPrivate stockholders at the special meeting. A Form 8-K disclosing the full voting results has been filed with the Securities and Exchange Commission. Additionally, the deadline for electing redemptions has passed, and 99.9% of funds will remain in InterPrivate s trust account as of closing. As a result, Aeva expects to receive approximately $563M in gross proceeds at the time of the business combination, which includes $320 million in expected gross proceeds from the private placements, which have been approve

Aeva and InterPrivate Acquisition Corp Announce Closing of Business Combination; Aeva to Trade on NYSE as AEVA Beginning On March 15

Aeva and InterPrivate Acquisition Corp. Announce Closing of Business Combination; Aeva to Trade on NYSE as “AEVA” Beginning On March 15 By Staff 2 weeks ago MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Aeva, Inc. (“Aeva” or the “Company”), a leader in next generation 4D LiDAR sensing and perception systems, announced today that it has completed its previously announced business combination with InterPrivate Acquisition Corp. (NYSE: IPV) (“InterPrivate”), a special purpose acquisition company. The transaction, which was approved by InterPrivate’s stockholders in a special meeting held on March 11, 2021, resulted in the combined company being renamed “Aeva Technologies, Inc.”, with its common stock and warrants to commence trading on the New York Stock Exchange on March 15, 2021 under the ticker symbols “AEVA” and “AEVAW”, respectively.

Rockcliff Metals Corp : Kinross Earns 70% Interest at Laguna Gold Property

Rockcliff Metals Corp.: Kinross Earns 70% Interest at Laguna Gold Property (CSE: RCLF) (FSE: RO0, WKN: A2H60G) ( Rockcliff or the Company ) is pleased to announce that an affiliate of Kinross Gold Corporation ( Kinross ) has earned a 70% interest in the Laguna/Lucky Jack/Puella Bay properties ( Laguna ) in Snow Lake, Manitoba. Rockcliff retains a 30% participating interest in Laguna. Pursuant to the July 2018 option agreement, Kinross has earned a 70% interest in Laguna by completing expenditures in excess of the required C$5,500,000 ahead of the third year anniversary of the six year option agreement. Having Kinross earn in so early on their option to the level of forming a Joint Venture on the Laguna Property confirms our belief of the high gold prospectivity of this land package. We look forward to seeing more encouraging results from this year s program currently underway. said Alistair Ross, President and CEO of Rockcliff.

Surface Oncology to Collaborate with Merck on Immuno-Oncology Study Evaluating SRF388,

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Surface Oncology to Collaborate with Merck on Immuno-Oncology Study Evaluating SRF388, . Surface Oncology, Inc.March 9, 2021 GMT CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) Surface Oncology  (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced today it has entered into a clinical trial collaboration with Merck, known as MSD outside the United States and Canada, through a subsidiary, to evaluate the safety and efficacy of combining Surface’s SRF388, an investigational antibody therapy targeting IL-27, with Merck’s KEYTRUDA® (pembrolizumab), the first anti-PD-1 therapy approved in the United States. This combination will be studied as a component of the first-in-human Phase 1 study of SRF388 and will be evaluated in patients with solid tumors, with a focus on patients with liver c

Energy Fuels Receives First Shipments of Natural Monazite Ore; Commercial Recovery of Rare Earths Expected to Begin in U S in Coming Weeks

Share this article Share this article Energy Fuels expects to commercially produce an intermediate rare earth element product at a stage more advanced than any other U.S. company. LAKEWOOD, Colo, March 9, 2021 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) ( Energy Fuels or the Company ) is pleased to announce that the first shipments of natural monazite ore arrived at the Company s White Mesa Mill (the Mill ) in Blanding, Utah this past weekend. This material was separated by The Chemours Company at its Offerman Mineral Sand Plant in Georgia and transported by truck to the Mill. In the coming weeks, Energy Fuels expects to gradually ramp-up production of an intermediate rare earth element ( REE ) product, called a mixed REE carbonate. This product will then advance to REE separation, which is the next stage in the REE value chain. Energy Fuels also expects to recover the uranium in the ore, which will be used as fuel for the generation of clean, carbo

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.